FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2574684127> ?p ?o ?g. }

• W2574684127 abstract "The detection of cancerous cells by the immune system elicits spontaneous antitumour im-mune responses. Still, during their progression, tumours acquire characteristics that enable them to escape immune surveillance. Cancer immunotherapy aims to reverse tumour im-mune evasion by activating and directing the immune system against transformed tumour cells. However, the tumours’ intrinsic resistance mechanisms limit the success of many im-munotherapeutic approaches. The functionally and morphologically abnormal tumour vascu-lature forms a physical barrier and prevents the entry of tumour-reactive immune effector cells, while the immunosuppressive tumour microenvironment impairs their function. To block tumour immune evasion, therapeutic strategies are being developed that combine cancer immunotherapy with treatment modalities, such as radiotherapy, that reprogram the tumour microenvironment to increase treatment efficacies and improve clinical outcome. In various preclinical models radiotherapy was shown to enhance the efficacy of adoptive T cell therapy. Our group showed that in the RIP1-TAg5 mouse model of spontaneous insulinoma, the transfer of in vitro-activated tumour-specific T cells induces T cell infiltration and pro-motes long-term survival only in combination with neoadjuvant local low dose irradiation (LDI). These treatment effects were mediated by iNOS+ macrophages.In this thesis, we investigated the mechanisms underlying the improved T cell infiltration and prolonged survival upon combination therapy with adoptive T cell transfer and local LDI. We demonstrate that combination therapy leads to a normalization of the aberrant tumour vas-culature and endothelial activation, an increase in intratumoural macrophages, a reduction of intratumoural myeloid derived suppressor cells and, most importantly, to tumour regres-sion. These findings suggest that this treatment inhibits tumour immune suppression but also facilitates immune effector cell infiltration through the normalization of the tumour vasculature, finally leading to tumour immune rejection. Inhibition of the inducible nitric oxide (NO) synthase (iNOS) revealed that these effects largely depend on its activity. Of note, the stimulation of human endothelial cells with low doses of the NO donor DETA NONOate activates the endothelial cells to upregulate adhesion molecules, indicating that in response to the combination therapy, iNOS-derived NO directly activates tumour endothelial cells, thereby promoting T cell infiltration and tumour immune rejection.Moreover, adoptive transfer of low dose irradiated peritoneal macrophages into unirradiat-ed RIP1-TAg5 mice prior to adoptive T cell transfer resulted in effects corresponding to the combination treatment, which highlights the role of macrophages in this mechanism. Whole transcriptome analysis of the irradiated peritoneal macrophages revealed that LDI causes gene expression and functional changes in these cells. Specifically, LDI activated interferon signalling and induced the upregulation of interferon regulated genes. This effect is likely due to the detection of danger signals released from damaged cells, which primes macro-phages and induces a shift in their polarization state. Signal transduction and amplification of interferon responses is mediated by interferon regulatory factors like IRF7. These transcription factors induce the expression of proinflammatory genes such as Nos2. Irf7 but also Nos2 and various proinflammatory genes like tumour necrosis factor (Tnf) were upregulated in response to LDI. Since NO and TNF-α are mediators of endothelial activation, this finding represents the link between LDI and macrophage-mediated activation of the tumour endothelium.In conclusion, the presented thesis demonstrates that macrophages with proinflammatory phenotypes are required for the activation of tumour endothelial cells, which in turn is criti-cal for the infiltration of immune effector cells and, thereby, for tumour immune destruction. Therefore these findings are of great importance for future immunotherapeutic approaches in the treatment of cancer patients." @default.
• W2574684127 created "2017-01-26" @default.
• W2574684127 creator A5010595971 @default.
• W2574684127 date "2016-01-01" @default.
• W2574684127 modified "2023-09-25" @default.
• W2574684127 title "Molecular Mechanisms of Macrophage Activation Induced by the Synergistic Effects of Low Dose Irradiation and Adoptive T Cell Therapy" @default.
• W2574684127 doi "https://doi.org/10.11588/heidok.00022419" @default.
• W2574684127 hasPublicationYear "2016" @default.
• W2574684127 type Work @default.
• W2574684127 sameAs 2574684127 @default.
• W2574684127 citedByCount "0" @default.
• W2574684127 crossrefType "dissertation" @default.
• W2574684127 hasAuthorship W2574684127A5010595971 @default.
• W2574684127 hasConcept C10882517 @default.
• W2574684127 hasConcept C126322002 @default.
• W2574684127 hasConcept C1491633281 @default.
• W2574684127 hasConcept C203014093 @default.
• W2574684127 hasConcept C2776090121 @default.
• W2574684127 hasConcept C2776107976 @default.
• W2574684127 hasConcept C2777701055 @default.
• W2574684127 hasConcept C502942594 @default.
• W2574684127 hasConcept C509974204 @default.
• W2574684127 hasConcept C54355233 @default.
• W2574684127 hasConcept C71924100 @default.
• W2574684127 hasConcept C86803240 @default.
• W2574684127 hasConcept C8891405 @default.
• W2574684127 hasConcept C90375314 @default.
• W2574684127 hasConceptScore W2574684127C10882517 @default.
• W2574684127 hasConceptScore W2574684127C126322002 @default.
• W2574684127 hasConceptScore W2574684127C1491633281 @default.
• W2574684127 hasConceptScore W2574684127C203014093 @default.
• W2574684127 hasConceptScore W2574684127C2776090121 @default.
• W2574684127 hasConceptScore W2574684127C2776107976 @default.
• W2574684127 hasConceptScore W2574684127C2777701055 @default.
• W2574684127 hasConceptScore W2574684127C502942594 @default.
• W2574684127 hasConceptScore W2574684127C509974204 @default.
• W2574684127 hasConceptScore W2574684127C54355233 @default.
• W2574684127 hasConceptScore W2574684127C71924100 @default.
• W2574684127 hasConceptScore W2574684127C86803240 @default.
• W2574684127 hasConceptScore W2574684127C8891405 @default.
• W2574684127 hasConceptScore W2574684127C90375314 @default.
• W2574684127 hasLocation W25746841271 @default.
• W2574684127 hasOpenAccess W2574684127 @default.
• W2574684127 hasPrimaryLocation W25746841271 @default.
• W2574684127 hasRelatedWork W106077952 @default.
• W2574684127 hasRelatedWork W1518184777 @default.
• W2574684127 hasRelatedWork W1752052039 @default.
• W2574684127 hasRelatedWork W1850149458 @default.
• W2574684127 hasRelatedWork W1979859887 @default.
• W2574684127 hasRelatedWork W2023211059 @default.
• W2574684127 hasRelatedWork W2040403545 @default.
• W2574684127 hasRelatedWork W2126555357 @default.
• W2574684127 hasRelatedWork W2127176453 @default.
• W2574684127 hasRelatedWork W2556502557 @default.
• W2574684127 hasRelatedWork W2910484443 @default.
• W2574684127 hasRelatedWork W2942960289 @default.
• W2574684127 hasRelatedWork W2952605014 @default.
• W2574684127 hasRelatedWork W3118744105 @default.
• W2574684127 hasRelatedWork W3137351506 @default.
• W2574684127 hasRelatedWork W3160680378 @default.
• W2574684127 hasRelatedWork W3162426238 @default.
• W2574684127 hasRelatedWork W3186484195 @default.
• W2574684127 hasRelatedWork W3192000496 @default.
• W2574684127 hasRelatedWork W3210261039 @default.
• W2574684127 isParatext "false" @default.
• W2574684127 isRetracted "false" @default.
• W2574684127 magId "2574684127" @default.
• W2574684127 workType "dissertation" @default.